RedHill Biopharma (RDHL) Accounts Payables (2011 - 2025)
RedHill Biopharma (RDHL) posted quarterly Accounts Payables of $731000.0 for Q4 2025, down 37.41% year-over-year from $1.2 million in Q4 2024, and down 12.46% quarter-over-quarter from $835000.0 in Q2 2025.
RedHill Biopharma (RDHL) Accounts Payables (2011 - 2025) Analysis & Trends
RedHill Biopharma (RDHL) has reported Accounts Payables for 15 consecutive years, with $731000.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Accounts Payables fell 37.41% year-over-year to $731000.0; the TTM figure through Dec 2025 stood at $731000.0 (down 37.41% YoY), while the FY2025 annual figure was $731000.0, down 37.41% from the prior year.
- Accounts Payables slipped to $731000.0 in Q4 2025 per RDHL's latest filing, from $835000.0 in the prior quarter.
- Across five years, Accounts Payables topped out at $15.2 million in Q3 2021 and bottomed at $731000.0 in Q4 2025.
- Historically, Accounts Payables has averaged $5.4 million across 5 years, with a median of $4.4 million in 2023.
- Annual changes were most pronounced in 2021 — Accounts Payables surged 150.68% — and 2022, when it tumbled 68.62%.
- RedHill Biopharma's Accounts Payables stood at $11.7 million in 2021, then plunged by 63.73% to $4.2 million in 2022, then dropped by 22.51% to $3.3 million in 2023, then slumped by 64.37% to $1.2 million in 2024, then sank by 37.41% to $731000.0 in 2025.
- Business Quant data shows RDHL's Accounts Payables at $731000.0 in Q4 2025, $835000.0 in Q2 2025, and $1.2 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | -5.09 Bn |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | 2.72 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | 452.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 2.80 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 497.80 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 1.73 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 808.30 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 427.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | 356.00 Mn |
| 10 | RedHill Biopharma | 2.05 Bn | 2.05 Bn | - | 731,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 731,000.00 |
| Jun 30, 2025 | 835,000.00 |
| Dec 31, 2024 | 1.17 Mn |
| Jun 30, 2024 | 1.91 Mn |
| Dec 31, 2023 | 3.28 Mn |
| Jun 30, 2023 | 3.11 Mn |
| Mar 31, 2023 | 4.37 Mn |
| Dec 31, 2022 | 4.23 Mn |
| Sep 30, 2022 | 4.78 Mn |
| Jun 30, 2022 | 4.37 Mn |
| Mar 31, 2022 | 5.71 Mn |
| Dec 31, 2021 | 11.66 Mn |
| Sep 30, 2021 | 15.25 Mn |
| Jun 30, 2021 | 13.31 Mn |
| Mar 31, 2021 | 6.54 Mn |
| Dec 31, 2020 | 11.55 Mn |
| Sep 30, 2020 | 6.57 Mn |
| Jun 30, 2020 | 5.31 Mn |
| Mar 31, 2020 | 3.19 Mn |
| Dec 31, 2019 | 4.18 Mn |